🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapy

Surgical Oncology Insight(2025)10.1016/j.soi.2025.100131Source: DataRank Database

Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapy is a research paper published in Surgical Oncology Insight (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: bronzeTopics (8)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Elliott J. Yee ORCID,Patrick Hosokawa ORCID,William A. Robinson ORCID,Theresa Medina ORCID,Luke Mantle

Live enrichment

PubMed:40207185 PMC:PMC11981639

National Institutes of Health National Cancer Institute

Grant: P30CA046934

National Institutes of Health

Grant: 3P30CA046934-20S2

Cancer Center Support Grant

National Institutes of Health

bronzeLicense: CC BY NC ND

publisherhttps://www.surgoncinsight.org/article/S2950-2470(25)00010-6/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2950247025000106?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2950247025000106?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11981639/pdf/nihms-2063973.pdf

Europe_PMChttps://europepmc.org/articles/PMC11981639

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

ImmunotherapyLymphadenectomyImmune Checkpoint InhibitorsStage Iii MelanomaTherapeutic Lymph Node DissectionArticle